10-Q/A Filing

Astrana Health, Inc. CIK: 1083446 Q2 2015

Filing Information

Form Type	10-Q/A
Accession Number	`0001144204-15-066403`
Period End Date	20150930
Filing Date	20151117
Fiscal Year	2015
Fiscal Period	Q2
XBRL Instance	ameh-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 86 Cash Flow Statement 81

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.92M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.95M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.80M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$4.02M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$208.29K	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$289.06K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.86M	shares	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$20.05K	USD	Point-in-time
Due from affiliates	`DueFromAffiliateCurrent`	$36.40K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.86M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.86M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.86M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$410.01K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$278.92K	USD	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	-	USD	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	$513.65K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.66M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.85M	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$264.71K	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$250.03K	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$217.96K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$582.47K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$577.70K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.28M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.38M	USD	Point-in-time
Goodwill	`Goodwill`	$2.17M	USD	Point-in-time
Goodwill	`Goodwill`	$2.17M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$212.15K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$218.72K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$13.65M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.00M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.94M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.35M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.34M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.26M	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$7.28M	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$327.14K	USD	Point-in-time
Note and line of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$7.39M	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	$1.04M	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	$2.55M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesCurrent`	$6.69M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesCurrent`	$1.32M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesCurrent`	$1.48M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.98M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.43M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	$6.23M	USD	Point-in-time
Notes payable, net of discount, non-current portion	`LongTermNotesPayable`	-	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Convertible notes payable, net of discount	`ConvertibleLongTermNotesPayable`	$1.46M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.14M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$171.22K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$177.34K	USD	Point-in-time
Total liabilities	`Liabilities`	$15.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$17.61M	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES AND SUBSEQUENT EVENTS (NOTES 10 and 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES AND SUBSEQUENT EVENTS (NOTES 10 and 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 4,863,389 shares issued and outstanding as of September 30, 2015 and March 31, 2015	`CommonStockValue`	$4.86K	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 4,863,389 shares issued and outstanding as of September 30, 2015 and March 31, 2015	`CommonStockValue`	$4.86K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$16.52M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$16.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-22.35M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.34M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.82M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-5.68M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.72M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.83M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-990.18K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.96M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$15.00M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$13.65M	USD	Point-in-time

Income Statement 86 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$11.67M	USD	1 Quarter
Net revenues	`Revenues`	$11.37M	USD	1 Quarter
Net revenues	`Revenues`	$15.76M	USD	2 Qtrs
Net revenues	`Revenues`	$21.57M	USD	2 Qtrs
Cost of services	`CostOfServices`	$9.42M	USD	2 Qtrs
Cost of services	`CostOfServices`	$15.83M	USD	2 Qtrs
Cost of services	`CostOfServices`	$6.16M	USD	1 Quarter
Cost of services	`CostOfServices`	$8.26M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.44M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.46M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.45M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.68M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$77.68K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$205.18K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$141.44K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$193.28K	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$11.78M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$15.09M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$23.65M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$9.81M	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-412.91K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$1.86M	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$671.88K	USD	2 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$-2.08M	USD	2 Qtrs
Interest expense	`InterestExpense`	$429.22K	USD	2 Qtrs
Interest expense	`InterestExpense`	$329.26K	USD	1 Quarter
Interest expense	`InterestExpense`	$109.95K	USD	1 Quarter
Interest expense	`InterestExpense`	$606.12K	USD	2 Qtrs
Interest expense	`InterestExpense`	$68.82K	USD	1 Quarter
Gain (loss) on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$152.14K	USD	1 Quarter
Gain (loss) on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$122.14K	USD	2 Qtrs
Gain (loss) on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$96.85K	USD	1 Quarter
Gain (loss) on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$382.13K	USD	1 Quarter
Gain (loss) on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$-116.87K	USD	2 Qtrs
Other	`OtherNonoperatingIncomeExpense`	$-95.09K	USD	1 Quarter
Other	`OtherNonoperatingIncomeExpense`	$5.91K	USD	2 Qtrs
Other	`OtherNonoperatingIncomeExpense`	$-58.44K	USD	1 Quarter
Other	`OtherNonoperatingIncomeExpense`	$-60.91K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-544.90K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-540.17K	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-67.06K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-235.55K	USD	1 Quarter
(Loss) income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-479.96K	USD	1 Quarter
(Loss) income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.62M	USD	2 Qtrs
(Loss) income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.62M	USD	1 Quarter
(Loss) income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$126.97K	USD	2 Qtrs
Income tax (benefit) provision	`IncomeTaxExpenseBenefit`	$-186.14K	USD	1 Quarter
Income tax (benefit) provision	`IncomeTaxExpenseBenefit`	$-93.45K	USD	2 Qtrs
Income tax (benefit) provision	`IncomeTaxExpenseBenefit`	$98.59K	USD	2 Qtrs
Income tax (benefit) provision	`IncomeTaxExpenseBenefit`	$86.99K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-293.83K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$1.54M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-2.52M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$28.38K	USD	2 Qtrs
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$489.40K	USD	2 Qtrs
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$329.81K	USD	2 Qtrs
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$237.54K	USD	1 Quarter
Net income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$159.61K	USD	1 Quarter
Net (loss) income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-531.37K	USD	1 Quarter
Net (loss) income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$1.38M	USD	1 Quarter
Net (loss) income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-301.43K	USD	2 Qtrs
Net (loss) income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-3.01M	USD	2 Qtrs
Unrealized gain on change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$14.50K	USD	1 Quarter
Unrealized gain on change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$33.09K	USD	2 Qtrs
Unrealized gain on change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	2 Qtrs
Unrealized gain on change in value of marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-268.34K	USD	2 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-3.01M	USD	2 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$1.39M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-531.37K	USD	1 Quarter
BASIC	`EarningsPerShareBasic`	$-0.06	USD	2 Qtrs
BASIC	`EarningsPerShareBasic`	$-0.11	USD	1 Quarter
BASIC	`EarningsPerShareBasic`	$-0.62	USD	2 Qtrs
BASIC	`EarningsPerShareBasic`	$0.28	USD	1 Quarter
DILUTED	`EarningsPerShareDiluted`	$-0.11	USD	1 Quarter
DILUTED	`EarningsPerShareDiluted`	$-0.62	USD	2 Qtrs
DILUTED	`EarningsPerShareDiluted`	$-0.06	USD	2 Qtrs
DILUTED	`EarningsPerShareDiluted`	$0.26	USD	1 Quarter
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	4.91M	shares	2 Qtrs
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	4.86M	shares	1 Quarter
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	4.86M	shares	2 Qtrs
BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	4.91M	shares	1 Quarter
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.91M	shares	2 Qtrs
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.86M	shares	2 Qtrs
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.44M	shares	1 Quarter
DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	4.86M	shares	1 Quarter

Cash Flow Statement 81 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$-293.83K	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$1.54M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$-2.52M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$28.38K	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$77.68K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$205.18K	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$141.44K	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$193.28K	USD	1 Quarter
Deferred income tax	`DeferredIncomeTaxExpenseBenefit`	$59.31K	USD	2 Qtrs
Deferred income tax	`DeferredIncomeTaxExpenseBenefit`	$6.13K	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$152.73K	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$68.89K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$975.66K	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$856.52K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$62.28K	USD	2 Qtrs
Amortization of financing costs	`AdjustmentForAmortization`	$46.74K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$177.96K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$-47.88K	USD	2 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$152.14K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$122.14K	USD	2 Qtrs
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$96.85K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$382.13K	USD	1 Quarter
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-116.87K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$993.67K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$214.13K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$5.38M	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$80.78K	USD	2 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-16.34K	USD	2 Qtrs
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-42.38K	USD	2 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$14.17K	USD	2 Qtrs
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$131.09K	USD	2 Qtrs
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	-	USD	2 Qtrs
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	$-513.65K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$347.00	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-6.57K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.59M	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.17M	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$668.78K	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$76.64K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-328.83K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.12M	USD	2 Qtrs
Acquisition, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.95M	USD	2 Qtrs
Acquisition, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$15.58K	USD	2 Qtrs
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$42.57K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.96M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-42.57K	USD	2 Qtrs
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$2.00M	USD	2 Qtrs
Principal payments on term note payable	`PrincipalPaymentsOnTermNotePayable`	$122.50K	USD	2 Qtrs
Principal payments on term note payable	`PrincipalPaymentsOnTermNotePayable`	$726.08K	USD	2 Qtrs
Contribution by non-controlling interest	`ProceedsFromMinorityShareholders`	-	USD	2 Qtrs
Contribution by non-controlling interest	`ProceedsFromMinorityShareholders`	$550.00K	USD	2 Qtrs
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$595.42K	USD	2 Qtrs
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$600.00K	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$20.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.20M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-717.92K	USD	2 Qtrs
NET DECREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.09M	USD	2 Qtrs
NET DECREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.88M	USD	2 Qtrs
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.92M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.95M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.92M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.95M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Interest paid	`InterestPaid`	$356.20K	USD	2 Qtrs
Interest paid	`InterestPaid`	$380.75K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$18.59K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$32.20K	USD	2 Qtrs
Holdback liability	`AcquisitionRelatedHoldbackLiabilityConsideration`	$136.82K	USD	2 Qtrs
Holdback liability	`AcquisitionRelatedHoldbackLiabilityConsideration`	-	USD	2 Qtrs
Convertible note warrant	`ConvertibleNoteWarrant`	$487.62K	USD	2 Qtrs
Convertible note warrant	`ConvertibleNoteWarrant`	-	USD	2 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	2 Qtrs
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$578.15K	USD	2 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	2 Qtrs
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$132.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.